Authors: Hyunho Shin
This study proposes an innovative therapeutic approach for Alzheimer’s disease (AD) targeting the aggregation and clearance of the neurotoxic amyloid-beta 42 (Aβ42) peptide. Utilizing computational design tools such as AlphaFold 2, we identified and optimized functional peptides capable of binding the hydrophobic C-terminal region of Aβ42 to prevent aggregation and promote degradation via the ubiquitin-proteasome system (UPS). This non-invasive strategy envisions peptide administration through a nasal ultrasonic nebulizer, which could bypass the blood-brain barrier (BBB) and deliver peptides directly to the brain. The concept focuses on the potential of combining targeted peptide design with a delivery system that enables rapid, brain-specific absorption, presenting a novel direction for AD therapy.
Comments: 10 Pages.
Download: PDF
[v1] 2024-11-03 22:54:12
Unique-IP document downloads: 138 times
Vixra.org is a pre-print repository rather than a journal. Articles hosted may not yet have been verified by peer-review and should be treated as preliminary. In particular, anything that appears to include financial or legal advice or proposed medical treatments should be treated with due caution. Vixra.org will not be responsible for any consequences of actions that result from any form of use of any documents on this website.
Add your own feedback and questions here:
You are equally welcome to be positive or negative about any paper but please be polite. If you are being critical you must mention at least one specific error, otherwise your comment will be deleted as unhelpful.